Vaginal Dryness: Causes, Treatments, and Why You Don't Have to Live with It

It starts subtly. Intercourse becomes uncomfortable, then outright painful. You notice irritation during everyday activities. You might develop recurrent urinary tract infections for the first time in your life. Your OB-GYN tells you everything looks normal. Your primary care doctor suggests lubricant. And you quietly start avoiding intimacy, because nobody has explained what's actually happening or told you there are effective treatments.

Vaginal dryness — more accurately called genitourinary syndrome of menopause (GSM) when related to hormonal changes — affects up to 50% of postmenopausal women. Unlike hot flashes, which often improve with time, GSM is progressive. Without treatment, it gets worse.

What's Actually Happening

The tissues of the vagina, vulva, and lower urinary tract are estrogen-dependent. When estrogen levels decline — whether from menopause, surgical removal of the ovaries, certain medications, breastfeeding, or other causes — these tissues undergo significant changes:

• Thinning of the vaginal epithelium — The cell layer becomes thinner and more fragile, leading to irritation and micro-tears
• Decreased vaginal blood flow — Less circulation means less natural lubrication and slower healing
• Loss of vaginal elasticity — The tissue becomes less flexible, contributing to pain with intercourse
• Changes in vaginal pH — The pH rises from the acidic range (3.5-4.5) to a more neutral range, disrupting the protective lactobacilli and increasing susceptibility to infections
• Urethral changes — The urethra shares embryonic origins with the vagina and is similarly estrogen-dependent. Atrophy can contribute to urinary urgency, frequency, and recurrent UTIs

Causes Beyond Menopause

While menopause is the most common cause, vaginal dryness can occur at any age:

• Breastfeeding — Elevated prolactin suppresses estrogen, causing temporary dryness
• Hormonal contraceptives — Some women experience dryness on certain birth control pills, especially low-estrogen formulations
• Anti-estrogen medications — Tamoxifen, aromatase inhibitors (used in breast cancer treatment)
• Chemotherapy and radiation — Can cause premature ovarian failure
• Sjögren's syndrome — Autoimmune condition affecting moisture-producing glands
• Surgical menopause — Bilateral oophorectomy causes abrupt estrogen loss
• Medications — Antihistamines, certain antidepressants, and allergy medications can reduce moisture
• Smoking — Accelerates estrogen metabolism and reduces blood flow to vaginal tissues
• Psychological factors — Anxiety, stress, and insufficient arousal can reduce lubrication

Treatment Options: From Simple to Medical

Non-Hormonal First Steps

Vaginal moisturizers — These are different from lubricants. Moisturizers (like Replens, Hyalo GYN, or similar products) are applied regularly (every 2-3 days) to maintain vaginal moisture, regardless of sexual activity. They work by adhering to the vaginal wall and gradually releasing moisture.

Lubricants — Used during sexual activity to reduce friction. Water-based lubricants are compatible with condoms and most toys but may need reapplication. Silicone-based lubricants last longer but are not compatible with silicone toys. Avoid lubricants with glycerin (can promote yeast), warming/cooling agents, or fragrances.

Regular sexual activity — Vaginal intercourse and other sexual stimulation increase blood flow to vaginal tissues, promote natural lubrication, and help maintain vaginal elasticity. This is genuinely evidence-based, not just folk wisdom.

Pelvic floor physical therapy — Can address pain patterns, muscle tension, and guarding behaviors that develop secondary to chronic vaginal discomfort.

Local (Vaginal) Estrogen

This is the gold standard for moderate to severe GSM, and it's dramatically underutilized. Local estrogen therapy delivers a small amount of estrogen directly to vaginal and urethral tissues, restoring thickness, elasticity, lubrication, and normal pH.

Key point: Local estrogen at standard doses results in minimal systemic absorption. Blood estrogen levels remain in the postmenopausal range. This means it's appropriate for many women who cannot or should not take systemic HRT.

Available formulations:

• Estradiol vaginal cream (Estrace) — Applied 2-3 times per week with a measured applicator
• Estradiol vaginal ring (Estring) — Inserted vaginally, releases a continuous low dose for 90 days. Set it and forget it.
• Estradiol vaginal tablet (Vagifem/Yuvafem) — Small tablet inserted vaginally twice weekly with an applicator
• Estradiol vaginal insert (Imvexxy) — Softgel capsule inserted vaginally, available in lower doses
• Prasterone (DHEA) vaginal insert (Intrarosa) — Converts locally to estrogen and testosterone. Technically not estrogen therapy, which matters for breast cancer survivors.

How quickly does it work? Most women notice improvement within 2-4 weeks, with full benefit by 8-12 weeks. The therapy needs to be continued long-term, as symptoms return when it's stopped.

Do you need progesterone with it? For standard-dose local estrogen, routine progesterone supplementation is generally not required, even in women with a uterus. This differs from systemic HRT, where progesterone is mandatory to protect the endometrium.

Non-Hormonal Prescriptions

Ospemifene (Osphena) — An oral selective estrogen receptor modulator (SERM) that has estrogenic effects on vaginal tissue without stimulating the breast or endometrium significantly. Taken as a daily pill. An option for women who prefer oral medication or cannot use vaginal estrogen.

Prasterone (Intrarosa) — DHEA vaginal insert that works through intracrine conversion to estrogen and androgens within vaginal cells. Classified differently from estrogen therapy, which may be relevant for breast cancer survivors.

Emerging Treatments

Vaginal laser therapy (CO2 fractional laser or erbium:YAG) — Creates controlled micro-injuries to stimulate collagen production and vaginal tissue remodeling. FDA-cleared devices exist, but the FDA has warned against marketing them specifically for vaginal "rejuvenation" or GSM treatment due to limited long-term evidence. Some studies show benefit comparable to local estrogen, but more data is needed.

Platelet-rich plasma (PRP) — Injection of concentrated growth factors into vaginal tissue. Early-stage evidence only; not recommended as standard treatment.

For Breast Cancer Survivors

This deserves special attention because breast cancer survivors are frequently told they cannot use any estrogen, leaving them to suffer with severe GSM. The reality is more nuanced:

• Non-hormonal options should always be tried first: moisturizers, lubricants, ospemifene (though this is contraindicated with tamoxifen), pelvic floor therapy
• Low-dose vaginal estrogen — Major organizations including NAMS and ACOG have stated that low-dose vaginal estrogen may be considered for breast cancer survivors with severe GSM who don't respond to non-hormonal options, particularly those not on aromatase inhibitors. This should be a shared decision with the patient's oncologist.
• Prasterone (DHEA) vaginal inserts — Because the hormonal conversion happens locally (intracrine), systemic levels are minimally affected. May be considered with oncology consultation.

When to Seek Help

Don't wait until symptoms are severe. Seek evaluation if you have:

• Pain during intercourse that is new or worsening
• Vaginal irritation, burning, or itching that doesn't resolve
• Recurrent UTIs (3 or more per year)
• Urinary urgency or frequency not explained by other causes
• Vaginal bleeding after intercourse or outside of expected periods
• Any vaginal symptoms that are affecting your quality of life or relationships

The Conversation Nobody Has

Vaginal dryness is one of the most common conditions that goes untreated because patients are embarrassed to bring it up and providers don't routinely ask about it. Studies show that only 25% of symptomatic women seek treatment, and only 4% of postmenopausal women use vaginal estrogen — despite it being safe, effective, and inexpensive.

You do not have to accept painful sex, chronic discomfort, or recurrent UTIs as an inevitable part of aging. Effective treatments exist, and most of them can be started and managed through telehealth.

[Start a visit at coral.clinic/start](https://coral.clinic/start). Dr. Kim can evaluate your symptoms, discuss treatment options, and prescribe appropriate therapy — all through a confidential telehealth visit. No waiting room. No awkward conversation in a paper gown. Just evidence-based medicine for a problem that has solutions.